Veterinary Medicine Information website

Nobivac DHPPiL Vet. pulver og solvens til injektionsvæske, suspension

Authorised
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
  • Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
Download as PDF

Product identification

Medicine name:
Nobivac DHPPiL Vet. pulver og solvens til injektionsvæske, suspension
Active substance:
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
  • Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
    957.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated
    625.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain Onderstepoort, Live
    10000.00
    50% tissue culture infectious dose
    /
    1.00
    Vial
  • Canine adenovirus 2, strain Manhattan LPV3, Live
    10000.00
    50% tissue culture infectious dose
    /
    1.00
    Vial
  • Canine parvovirus, strain 154, Live
    10000000.00
    50% tissue culture infectious dose
    /
    1.00
    Vial
  • Canine parainfluenza virus, strain Cornell, Live
    316228.00
    50% tissue culture infectious dose
    /
    1.00
    Vial
Pharmaceutical form:
  • Powder and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 14129
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 24/04/2026
Download